Literature DB >> 8905416

Polyneuropathies in critically ill patients: a prospective evaluation.

K Berek1, J Margreiter, J Willeit, A Berek, E Schmutzhard, N J Mutz.   

Abstract

OBJECTIVE: To determine the incidence, severity and course of polyneuropathies in patients with sepsis or systemic inflammatory response syndrome combined with multiple organ failure.
DESIGN: Prospective study.
SETTING: Division of Intensive Care Medicine of the Department of Anesthesiology and Intensive Care and Intensive Care Unit of the Department of Neurology, University Hospital Innsbruck, Austria. PATIENTS: Twenty-two patients between 23 and 77 years old with sepsis or systemic inflammatory response syndrome combined with multiple organ failure fulfilling strict inclusion and exclusion criteria.
INTERVENTIONS: Clinical neurologic examination and electro myography/nerve conduction velocity measurements during the stay on the Intensive Care Unit and 2-3 months later. MEASUREMENTS AND
RESULTS: In 9 of the 22 patients signs of polyneuropathy were found at the initial clinical investigation and in 7 patients at the follow-up investigation. Electrophysiologic investigation revealed signs of polyneuropathy in 18 patients initially and in 11 patients 2-3 months later.
CONCLUSION: In our patient population the frequency of the development of polyneuropathy was high (81.8%). Electrophysiologic investigation is superior to clinical neurologic examination in the detection of polyneuropathies.

Entities:  

Mesh:

Year:  1996        PMID: 8905416     DOI: 10.1007/bf02044106

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  21 in total

1.  Acute polyneuropathy in critically ill patients.

Authors:  K Berek; E Schmutzhard; M Neumann; H P Haring; B Pfausler; A Berek; M Kofler
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Chronic inflammatory demyelinating polyradiculoneuropathy: features and prognostic factors with corticosteroid therapy.

Authors:  E Wertman; Z Argov; O Abrmasky
Journal:  Eur Neurol       Date:  1988       Impact factor: 1.710

3.  Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome.

Authors:  C F Bolton; D A Laverty; J D Brown; N J Witt; A F Hahn; W J Sibbald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

4.  [Disseminated polyneuropathy after coma].

Authors:  F Grahmann; B Neundörfer; F Erbguth
Journal:  Dtsch Med Wochenschr       Date:  1989-10-27       Impact factor: 0.628

5.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure.

Authors:  D W Zochodne; C F Bolton; G A Wells; J J Gilbert; A F Hahn; J D Brown; W A Sibbald
Journal:  Brain       Date:  1987-08       Impact factor: 13.501

6.  [Electrophysiologic studies in polyneuropathy of intensive care patients].

Authors:  B J Ebeling; K Rommelsheim; H Stoeckel
Journal:  Anasth Intensivther Notfallmed       Date:  1990-12

Review 7.  Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture.

Authors:  P J Dyck
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

8.  Multiple-organ failure. Generalized autodestructive inflammation?

Authors:  R J Goris; T P te Boekhorst; J K Nuytinck; J S Gimbrère
Journal:  Arch Surg       Date:  1985-10

9.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09

10.  Acute polyneuropathy in critically ill patients.

Authors:  J B Lopez Messa; A García
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

View more
  43 in total

1.  Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome.

Authors:  C F Bolton
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

2.  Critical Illness Polyneuropathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

3.  Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both?

Authors:  Nicola Latronico
Journal:  Intensive Care Med       Date:  2003-09       Impact factor: 17.440

Review 4.  Intensive care unit-acquired weakness: implications for physical therapist management.

Authors:  Amy Nordon-Craft; Marc Moss; Dianna Quan; Margaret Schenkman
Journal:  Phys Ther       Date:  2012-01-26

Review 5.  [Cellular regulation of anabolism and catabolism in skeletal muscle during immobilisation, aging and critical illness].

Authors:  Eva-Maria Strasser; Barbara Wessner; Erich Roth
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  The role of endotoxin in critical illness myopathy and polyneuropathy.

Authors:  Jörg Ahrens; Martin Leuwer; Nilufar Foadi; Gertrud Haeseler
Journal:  J Neurol       Date:  2009-03-22       Impact factor: 4.849

7.  Review of Critical Illness Myopathy and Neuropathy.

Authors:  Starane Shepherd; Ayush Batra; David P Lerner
Journal:  Neurohospitalist       Date:  2016-08-23

Review 8.  Neuromuscular conditions in the intensive care unit.

Authors:  C F Bolton
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

9.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

10.  Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study.

Authors:  Vasiliki Gerovasili; Konstantinos Stefanidis; Konstantinos Vitzilaios; Eleftherios Karatzanos; Panagiotis Politis; Apostolos Koroneos; Aikaterini Chatzimichail; Christina Routsi; Charis Roussos; Serafim Nanas
Journal:  Crit Care       Date:  2009-10-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.